ReviewFrontiers in oncology2015

Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet.

Grant A McArthurPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.